BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 18996461)

  • 1. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles.
    Li G; Badkar A; Nema S; Kolli CS; Banga AK
    Int J Pharm; 2009 Feb; 368(1-2):109-15. PubMed ID: 18996461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microneedles for transdermal drug delivery.
    Prausnitz MR
    Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
    Al-Qallaf B; Das DB
    Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of solid maltose microneedles and their use for transdermal delivery.
    Kolli CS; Banga AK
    Pharm Res; 2008 Jan; 25(1):104-13. PubMed ID: 17597381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microchannels created by sugar and metal microneedles: characterization by microscopy, macromolecular flux and other techniques.
    Li G; Badkar A; Kalluri H; Banga AK
    J Pharm Sci; 2010 Apr; 99(4):1931-41. PubMed ID: 19894263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery.
    Yan G; Warner KS; Zhang J; Sharma S; Gale BK
    Int J Pharm; 2010 May; 391(1-2):7-12. PubMed ID: 20188808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.
    Wu Y; Qiu Y; Zhang S; Qin G; Gao Y
    Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal drug delivery using disk microneedle rollers in a hairless rat model.
    Kim HM; Lim YY; An JH; Kim MN; Kim BJ
    Int J Dermatol; 2012 Jul; 51(7):859-63. PubMed ID: 22715835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced transdermal delivery of low molecular weight heparin by barrier perturbation.
    Lanke SS; Kolli CS; Strom JG; Banga AK
    Int J Pharm; 2009 Jan; 365(1-2):26-33. PubMed ID: 18801420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulated iontophoretic delivery of small and large molecules through microchannels.
    Kumar V; Banga AK
    Int J Pharm; 2012 Sep; 434(1-2):106-14. PubMed ID: 22633929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled transdermal delivery of model drug compounds by MEMS microneedle array.
    Xie Y; Xu B; Gao Y
    Nanomedicine; 2005 Jun; 1(2):184-90. PubMed ID: 17292077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Super-short solid silicon microneedles for transdermal drug delivery applications.
    Li WZ; Huo MR; Zhou JP; Zhou YQ; Hao BH; Liu T; Zhang Y
    Int J Pharm; 2010 Apr; 389(1-2):122-9. PubMed ID: 20096759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microneedles: an emerging transdermal drug delivery system.
    Bariya SH; Gohel MC; Mehta TA; Sharma OP
    J Pharm Pharmacol; 2012 Jan; 64(1):11-29. PubMed ID: 22150668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal delivery of methotrexate for pediatrics using silicon microneedles.
    Abla MJ; Chaturvedula A; O'Mahony C; Banga AK
    Ther Deliv; 2013 May; 4(5):543-51. PubMed ID: 23647273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication, characterization and application of sugar microneedles for transdermal drug delivery.
    Nguyen HX; Banga AK
    Ther Deliv; 2017 Mar; 8(5):249-264. PubMed ID: 28361607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein.
    Oh JH; Park HH; Do KY; Han M; Hyun DH; Kim CG; Kim CH; Lee SS; Hwang SJ; Shin SC; Cho CW
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1040-5. PubMed ID: 18411045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microneedles: a valuable physical enhancer to increase transdermal drug delivery.
    Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Molina-Trinidad E; Casas-Alancaster N; Revilla-Vázquez AL
    J Clin Pharmacol; 2011 Jul; 51(7):964-77. PubMed ID: 21148047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.
    Kolli CS; Xiao J; Parsons DL; Babu RJ
    Drug Dev Ind Pharm; 2012 May; 38(5):571-6. PubMed ID: 21980925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate.
    Vemulapalli V; Yang Y; Friden PM; Banga AK
    J Pharm Pharmacol; 2008 Jan; 60(1):27-33. PubMed ID: 18088502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo transdermal delivery of leuprolide using microneedles and iontophoresis.
    Sachdeva V; Zhou Y; Banga AK
    Curr Pharm Biotechnol; 2013; 14(2):180-93. PubMed ID: 23157712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.